NCT03533231

Brief Summary

This Study Was Made to Evaluate the Antibacterial Effect of Different Antibacterial Combinations on Revascularization Process in Permanent Anterior Immature Teeth. Immature Necrotic Permanent Maxillary Incisors (n = 40) of Patients 8-18 Years Old Were Divided Into 4 Equal Groups (Each n = 10) According to the Intracanal Medicament: Group 1 Was Treated With Triple Antibiotic Paste (TAP), Group 2 Was Treated With Ciprofloxacin + Propolis Paste (CP), Group 3 Was Treated With Ciprofloxacin + Metronidazole Paste (CM), Group 4 Was Treated With Propolis + Metronidazole Paste (PM). Cases Were Followed at Regular Intervals up to 18 Months Clinically and Radiographically.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Jan 2015

Typical duration for phase_4

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 16, 2015

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2017

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2018

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 24, 2018

Completed
29 days until next milestone

First Posted

Study publicly available on registry

May 23, 2018

Completed
Last Updated

May 30, 2018

Status Verified

May 1, 2018

Enrollment Period

2.7 years

First QC Date

April 24, 2018

Last Update Submit

May 25, 2018

Conditions

Keywords

Pulp regeneration, intracanal medication

Outcome Measures

Primary Outcomes (4)

  • Change in periapical pathosis

    Change in periapical bone density on follow up radiographs

    baseline, 3 months, 6 months, 9 months, 12 months, and 18 months

  • Change in root length

    Change in root length on follow up radiographs

    baseline, 3 months, 6 months, 9 months, 12 months, and 18 months

  • Change in root thickness

    Change in root thickness on follow up radiographs

    baseline, 3 months, 6 months, 9 months, 12 months, and 18 months

  • Change in apical diameter

    Change in apical diameter on follow up radiographs

    baseline, 3 months, 6 months, 9 months, 12 months, and 18 months

Study Arms (4)

Triple Antibiotic Paste (TAP)

ACTIVE COMPARATOR

It consisted of Ciprofloxacin (Ciprocin 250 mg tablets; EPICO, Cairo, Egypt), Metronidazole (Flagyl 500 mg tablets; Sanofi Aventis Pharma, Cairo, Egypt), Doxycycline (Vibramycin 100 mg capsules; Pfizer, Cairo, Egypt). One Doxycycline capsule content was evacuated in a sterile mortar, one tablet of metronidazole and one tablet of ciprofloxacin were crushed and ground in the same mortar using a pestle into homogenous powder. Saline drops (Otrivin baby saline; Novartis, Cairo, Egypt) were added and mixed using the pestle until a creamy paste was achieved (Sabrah et al. 2013, Nagy et al. 2014). TAP was then used for canal disinfection.

Combination Product: Canal Disinfection Triple Antibiotic Paste (TAP)

Ciprofloxacin + Propolis Paste

EXPERIMENTAL

Ethanol extract of raw propolis (EEP; ElEzaby Co. Labs, Cairo, Egypt.) was prepared by adding 10 gm of propolis (Imtinan, Cairo, Egypt) to 40 gm of 70% ethanol (ElGomhorya Co., Cairo, Egypt) (for 20% tincture) in a dark container to prevent reduction of propolis. The container was sealed and placed at room temperature for a period of three weeks. The sealed container was manually shaken every 2 days to ensure proper mixing. After 3 weeks, the container was opened and ethanol extract of propolis was obtained. Ethanol-free EEP was made by evaporating the ethanol in a water bath. EEP was then mixed with Ciprofloxacin powder in the ratio 1:1. Saline drops were added and mixed using the pestle until a creamy paste was achieved. This paste was then used for canal disinfection.

Combination Product: Ciprofloxacin + Propolis Paste

Ciprofloxacin + Metronidazole Paste

ACTIVE COMPARATOR

Ciprofloxacin powder was mixed with Metronidazole powder in the ratio 1:1. Saline drops were added and mixed using the pestle until a creamy paste was achieved. This paste was then used for canal disinfection.

Combination Product: Ciprofloxacin + Metronidazole Paste

Propolis + Metronidazole paste

EXPERIMENTAL

Ethanol Extract of Propolis (EEP) was mixed with Metronidazole powder in the ratio 1:1. Saline drops were added and mixed using the pestle until a creamy paste was achieved. This paste was then used for canal disinfection.

Combination Product: Propolis + Metronidazole paste

Interventions

Patients were treated as follows: Caries was excavated; access cavity was prepared. The rubber dam was then applied and working length was determined. Canal space was irrigated using 40 cc of NaOCl 2.6% solution and final flush of saline. Canal space was dried using paper points. One cc of the prepared paste was injected into the canals using a sterile plastic syringe with 20" gauge needle. The access cavity was then sealed using temporary restoration. After the 3 weeks, anesthesia without vasoconstrictor was administrated. The antibiotic paste was removed and the canal was irrigated using a sterile saline and dried using paper points. Sterile hand file size #25 was introduced into the root canal beyond the working length to induce bleeding. The bleeding was allowed to reach a 3-mm level below the cemento-enamel junction. MTA was used to seal the root canal at the cervical level. After one week, adhesive composite resin was used to seal the access cavity.

Triple Antibiotic Paste (TAP)
Ciprofloxacin + Propolis Paste
Ciprofloxacin + Metronidazole Paste
Propolis + Metronidazole paste

Eligibility Criteria

Age8 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Permanent anterior teeth having immature apex.
  • Established radiographic periapical pathosis.
  • History of previous trauma.
  • Compliant patient/parent.

You may not qualify if:

  • teeth with vertical fractures, periodontally involved teeth, and nonrestorable teeth.
  • Patients with vital teeth.
  • Patients with heart disease or systemic disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Dental Pulp NecrosisPeriapical Abscess

Interventions

CiprofloxacinPropolis

Condition Hierarchy (Ancestors)

Dental Pulp DiseasesTooth DiseasesStomatognathic DiseasesNecrosisPathologic ProcessesPathological Conditions, Signs and SymptomsAbscessSuppurationInfectionsPeriapical PeriodontitisPeriapical DiseasesJaw DiseasesPeriodontal DiseasesMouth DiseasesPeriodontitis

Intervention Hierarchy (Ancestors)

Fluoroquinolones4-QuinolonesQuinolonesQuinolinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsResins, PlantBiopolymersPolymersMacromolecular SubstancesPlant ExudatesBiological ProductsComplex Mixtures

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Lecturer of Endodontics

Study Record Dates

First Submitted

April 24, 2018

First Posted

May 23, 2018

Study Start

January 16, 2015

Primary Completion

October 1, 2017

Study Completion

January 1, 2018

Last Updated

May 30, 2018

Record last verified: 2018-05